Comment on basal insulin plus bolus insulin or better plus GLP1-RA?

被引：0
|
作者：
Ritzel, Robert A. [1 ,2 ]
机构：
[1] Klin Bogenhausen, Chefarzt Endokrinol Diabetol & Angiol, Munich, Germany
[2] Klin Schwabing, Munich, Germany
来源：
DIABETOLOGIE UND STOFFWECHSEL | 2024年 / 19卷 / 01期
关键词：
D O I：
10.1055/a-2167-7456
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：30 / 31
页数：2
相关论文
共 50 条
  • [31] A case of an elderly patient with insulin-dependent diabetes and dementia receiving one basal insulin plus one bolus insulin injections a day for 6 months
    Taichi Minami
    Jun Shirakawa
    Akiko Kameda
    Yoichi Suzuki
    Kaoru Watanabe
    Taku Yamada
    Hiroko Hiiragi
    Soichiro Takeda
    Mayuko Takahashi
    Yasuo Terauchi
    Diabetology International, 2021, 12 : 135 - 139
  • [32] A case of an elderly patient with insulin-dependent diabetes and dementia receiving one basal insulin plus one bolus insulin injections a day for 6 months
    Minami, Taichi
    Shirakawa, Jun
    Kameda, Akiko
    Suzuki, Yoichi
    Watanabe, Kaoru
    Yamada, Taku
    Hiiragi, Hiroko
    Takeda, Soichiro
    Takahashi, Mayuko
    Terauchi, Yasuo
    DIABETOLOGY INTERNATIONAL, 2021, 12 (01) : 135 - 139
  • [33] Cost-effectiveness analyses of basal-bolus therapy of type-1 diabetes using insulin detemir plus human soluble insulin versus neutral protamine hagedorm plus human soluble insulin regimens in Germany
    Valentine, WJ
    Palmer, AJ
    Wittrup-Jensen, KU
    Roze, S
    VALUE IN HEALTH, 2005, 8 (06) : A163 - A163
  • [34] A comparison of the cost-effectiveness of basal-bolus therapy of Type 1 diabetes using insulin detemir plus insulin aspart versus human insulin-based regimens
    Palmer, AJ
    Roze, S
    Valentine, WJ
    Smith, IC
    Wittrup-Jensen, K
    DIABETOLOGIA, 2004, 47 : A344 - A344
  • [35] Clinical Impact of GLP-1 receptor agonists in veterans receiving basal-bolus insulin
    Hopton, Olivia M.
    Waterbury, Nancee, V
    Egge, Jason A.
    Lund, Brian C.
    PHARMACOTHERAPY, 2022, 42 (01): : 45 - 52
  • [36] The role of sulfonylurea plus basal insulin on glycemic variability compared to basal bolus regime in T2D patients
    Paula Vieira Freire
    Erika Bezerra Parente
    Cristal Peters Cabral
    Andre Carvalho Yamaya
    Caroline Schnoll
    Vivian Roberta Ferreia Simões
    Alessandra Muto
    Manoel Carlos Sampaio de Almeida Ribeiro
    João Eduardo Nunes Salles
    Diabetology & Metabolic Syndrome, 7 (Suppl 1):
  • [37] Type-2-Diabetes First Fixed Combination from Basal Insulin plus GLP-1-Analogs in a Pen
    不详
    DIABETES STOFFWECHSEL UND HERZ, 2014, 23 (06): : 349 - 351
  • [38] Basal/bolus with prandial inhaled Technosphere insulin plus insulin glargine vs biaspart 70/30 insulin in type 2 diabetes inadequately controlled on insulin with/without oral agents
    Gnudi, L.
    Lorber, D.
    Rosenstock, J.
    Howard, C.
    Petrucci, R.
    Shearer, D.
    Bilheimer, D.
    Chang, P. -C.
    Richardson, P.
    DIABETOLOGIA, 2009, 52 : S360 - S360
  • [39] Efficacy and safety of IDegLira (combination of insulin degludec plus liraglutide), in insulin-naive patients with type 2 diabetes uncontrolled on GLP-1 receptor agonist (GLP-1RA) therapy
    Linjawi, S.
    Bode, B. W.
    Chaykin, L. B.
    Courreges, J. -P.
    Handelsman, Y.
    Lehmann, L. M.
    Mishra, A.
    Simpson, R. W.
    DIABETOLOGIA, 2015, 58 : S401 - S402
  • [40] Comparison of Glycemic Variability and Hypoglycemic Events in Hospitalized Older Adults Treated with Basal Insulin plus Vildagliptin and Basal-Bolus Insulin Regimen: A Prospective Randomized Study
    Batule, Sol
    Ramos, Analia
    De Oca, Alejandra Perez-Montes
    Fuentes, Natalia
    Martinez, Santiago
    Raga, Joan
    Pena, Xoel
    Tural, Cristina
    Munoz, Pilar
    Soldevila, Berta
    Alonso, Nuria
    Umpierrez, Guillermo
    Puig-Domingo, Manel
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (10)
12345